In The Loop Banner

Managing Oral Chemotherapy
By Niesha Griffith, MS, RPh, FASHP; Julie Kennerly, PharmD, MS, BCPS; and Sarah Hudson-DiSalle, RPh, PharmD

Distinct advantages exist when comparing oral cancer agents (OCAs) to the traditional IV formulation anti-cancer agents. Patients who receive OCAs often report a greater sense of control over their treatment, less interference with daily work and social activities, reduced travel time and costs, and the elimination of discomfort associated with an IV line. Conversely, OCAs also present unique challenges, including the possibility of a significant medication error if a patient does not understand administration instructions; lack of patient adherence with more complicated regimens, potentially leading to over- or under-dosing; intensive monitoring requirements, special handling, and disposal requirements; as well as coverage and cost concerns. Therefore, developing a comprehensive OCA management plan and utilizing guidance from published resources is critical to ensure the effective and safe use of these medications. To read about how one hospital developed a broad plan to ensure proper management of OCAs, CLICK HERE.

Do You Know . . .
Is your hospital compliant with USP <800>? CLICK HERE to read about performing an assessment of risk to comply with the chapter.

Also Appearing in the March issue of PP&P
Special White Paper: Considerations for Insourcing Parenteral Nutrition
Sponsored by Baxter

Editor's Pick

Insourcing IV Compounding with Robotics
By Sara Bekri, PharmD, and Patrice Dupart, PharmD, BCPS, MSHCM

Typically, human touch is considered an asset in health care, allowing providers to form relationships with patients. Yet, the opposite is true when that care involves compounding and medication sterility. In the hospital pharmacy, touch contamination poses significant dangers to patient safety, with the potential to also impact patient satisfaction, extend lengths of stay, and ultimately affect hospital costs. The loss of entire batches of IV medications ruined by human contamination or a dosing miscalculation leads many hospitals to consider automating the compounding process. To read about how one hospital transitioned from outsourced compounding to insourcing with IV robotics, CLICK HERE.

Your Subscription
You are receiving this message as a subscriber to Pharmacy Purchasing & Products. If you would like to unsubscribe from our newsletters, please visit

If you are not already a subscriber to Pharmacy Purchasing & Products and would like to subscribe please go to:

Please remember to add us to your address book to ensure that you continue to receive our emails in your inbox.

Sponsorship/Advertising Opportunities
Please contact your account manager at or call 201-670-0077, ext. 200.

In the Loop © 2017 Ridgewood Medical Media, LLC. You have permission to forward In the Loop, in its entirety only, provided this copyright notice remains part of your transmission. To subscribe to In the Loop, please send an email to: and type "Subscribe, (Your email address, and full name)" in the body.

All other rights reserved. None of this material may be reprinted without the express written permission of Ridgewood Medical Media, LLC.
Effortless Vaccine Temperature Monitoring. InTemp CX400 Series. Onset. Watch the Video!

SmartPak. Smart thinking. Vancomycin Coming Soon. Samson Medical Technologies.

Media Test Kits help ensure that your facility and pharmacists are meeting compliance with <<USP 797>> regulations. Check out our entire line of low, medium, and high risk media test kits.

Somebody keep swiping your copy of PP&P? Subscribe today!